ID2

protein-coding

inhibitor of DNA binding 2, the group of Basic helix-loop-helix proteins

Gene summary

The protein encoded by this gene belongs to the inhibitor of DNA binding family, members of which are transcriptional regulators that contain a helix-loop-helix (HLH) domain but not a basic domain. Members of the inhibitor of DNA binding family inhibit the functions of basic helix-loop-helix transcription factors in a dominant-negative manner by suppressing their heterodimerization partners through the HLH domains. This protein may play a role in negatively regulating cell differentiation. A pseudogene of this gene is located on chromosome 3. [provided by RefSeq, Aug 2011]

MANE transcript

NM_002166.5

Inheritance

AD

ClinVar variants

U:23B:1

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 0

Max pathogenic AF

—

Genomic locus

chr2:8,678,845-8,684,461

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~5.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

congenital heart diseaseNO_KNOWN

Inheritance Pattern: AD

Disease ID:MONDO:0005453

Submitter: ClinGen

To date, *ID2* has not been reported in relation to congenital heart disease in humans. One missense mutation in ID2 was reported in a human causing developmental and epileptic encephalopathy, however the congenital heart phenotype was not mentioned (PMID: 31175295). The mechanism of disease is unknown. This gene-disease relationship is supported by two expression studies in the heart (PMID: 15472070, 17604724), and one mouse model that exhibits features of congenital heart disease including atrioventricular septal defect (PMID: 21330551). In summary, the evidence to support the gene-disease relationship between ID2 and congenital heart disease is disputed. More evidence is needed to either support or entirely refute the role ID2 plays in this disease. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 11/27/2023 (SOP Version 10)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ID2 variants in ClinVar

2 Conditions Cataloged
not specifiedTotal: 23
not providedTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_002166.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
missense
23
clinvar
23
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total00230124
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 11 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_002166.5RefSeqNP_002157.22MANE Select
ENST00000396290.2EnsemblENSP00000379585.12MANE Select
ENST00000234091.8EnsemblENSP00000234091.42Standard
ENST00000331129.3EnsemblENSP00000385465.22Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
id2aDanio rerio

Structure: retinal bipolar neuron

Quality: absent

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • TGF-beta signaling pathway - Homo sapiens (human)
  • Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human)
  • Hippo signaling pathway - Homo sapiens (human)
  • Transcriptional misregulation in cancer - Homo sapiens (human)
  • miRs in Muscle Cell Differentiation

Biological Process

  • negative regulation of transcription by RNA polymerase II
  • metanephros development
  • natural killer cell differentiation
  • thigmotaxis
  • membranous septum morphogenesis

Molecular Function

  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • RNA polymerase II transcription factor binding
  • DNA-binding transcription factor activity
  • protein binding
  • transcription factor binding

Cellular Component

  • nucleus
  • cytoplasm
  • cytosol
  • protein-containing complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000234091
Coding exons
2
Length
5609
Individuals with no LoFs
125733
Homozygous LoFs
0
Heterozygous LoFs
2
Defined
125735
p
0.00000795
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.01757373.40.9940.00000326892
Missense (PolyPhen)1522.8430.65666297
Synonymous-4.126332.91.910.00000156263
Loss of Function1.7603.600.001.53e-749

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.0000180.000018rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Transcriptional regulator (lacking a basic DNA binding domain) which negatively regulates the basic helix-loop-helix (bHLH) transcription factors by forming heterodimers and inhibiting their DNA binding and transcriptional activity. Implicated in regulating a variety of cellular processes, including cellular growth, senescence, differentiation, apoptosis, angiogenesis, and neoplastic transformation. Inhibits skeletal muscle and cardiac myocyte differentiation. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Restricts the CLOCK and ARNTL/BMAL1 localization to the cytoplasm. Plays a role in both the input and output pathways of the circadian clock: in the input component, is involved in modulating the magnitude of photic entrainment and in the output component, contributes to the regulation of a variety of liver clock-controlled genes involved in lipid metabolism. {ECO:0000269|PubMed:20861012}.;

Recessive Scores

pRec
0.493

Intolerance Scores

RVIS EVS
-0.19
RVIS percentile EVS
39.68

Essentials

Essential (CRISPR)
N
Indispensability pred.
E
Indispensability score
0.998

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.